title: Interactions between Mycobacterium leprae and simian immunodeficiency virus (SIV) in rhesus monkeys.
abstract: Groups of rhesus monkeys were inoculated with: 1) simian immunodeficiency virus (SIV)B670 alone; 2) Mycobacterium leprae alone; 3) SIV plus M. leprae on the same day; and 4) M. leprae 2 weeks after SIV. Animals were monitored at intervals for virus loads, antibody responses to M. leprae glycolipid antigens and to SIV Gp120, T-cell CD4+ and CD4+ CD29+ subset percentages, leprosy and acquired immunodeficiency syndrome (AIDS) clinical symptoms. Five out of six animals developed leprosy in each co-inoculated group, compared to one out of six in the M. leprae-only-inoculated group, indicating that M. leprae/SIV co-infection increases the susceptibility to leprosy, regardless of the timing of the two infections. Animals in the co-infected group that received M. leprae 2 weeks after SIV had a significantly slower rate of AIDS progression and long-term survival was significantly greater (three out of six) compared to the group inoculated with SIV alone (zero out of seven). All M. leprae-only-inoculated animals (six out of six) survived. Post-SIV-inoculation, a rapid decrease in the percentages of CD4 + and CD4 + CD29 + T-cells was observed in the SIV-only-inoculated group that was significantly blocked by co-inoculation with M. leprae 2 weeks after SIV, but not by SIV on the same day. The virus load set point was increased by approximately two logs in the group inoculated with M. leprae and SIV on the same day compared to SIV 2 weeks prior to M. leprae or the SIV-only-inoculated group. The results indicate that M. leprae, inoculated 2 weeks after SIV, decreased the pathogenicity of SIV compared to inoculation of M. leprae and SIV on the same day or SIV alone. The decreased pathogenicity correlated with a diminished loss of CD4 + and CD4 + CD29 + T-cell subsets in the group inoculated with M. leprae 2 weeks after SIV compared to the group inoculated with SIV alone. IgG antibody responses to M. leprae-specific cell wall phenolic glycolipid-I antigen were inhibited by 2-week-prior or same-day SIV co-inoculation compared to M. leprae-only inoculated animals. The IgG anti-lipoarabinomannan antibody response was enhanced in the group inoculated with M. leprae and SIV on the same day compared to the groups inoculated with M. leprae alone or SIV 2 weeks prior to M. leprae. Antibody responses to SIV Gp120 antigen were unimpaired in both co-inoculated groups compared to SIV-only-inoculated groups. The antibody results show that the immune responses to SIV and M. leprae are interrelated in SIV/M. leprae co-infected animals.
authors.affiliation: Department of Microbiology, Tulane University Regional Primate Research Center, Covington, LA 70433, USA. gormus@tpc.tulane.edu
authors.forename: B J
authors.initials: BJ
authors.lastname: Gormus
authors.forename: M
authors.initials: M
authors.lastname: Murphey-Corb
authors.forename: G B
authors.initials: GB
authors.lastname: Baskin
authors.forename: K
authors.initials: K
authors.lastname: Uherka
authors.forename: L N
authors.initials: LN
authors.lastname: Martin
authors.forename: P A
authors.initials: PA
authors.lastname: Marx
authors.forename: K
authors.initials: K
authors.lastname: Xu
authors.forename: M S
authors.initials: MS
authors.lastname: Ratterree
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D016516:CD4-CD8 Ratio; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D018450:Disease Progression; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D007074:Immunoglobulin G / Q000097:blood; D007918:Leprosy / Q000150:complications / Q000276:immunology / Q000503:physiopathology*; D008253:Macaca mulatta; D008562:Membrane Glycoproteins; D009166:Mycobacterium leprae / Q000302:isolation & purification; D012367:RNA, Viral / Q000097:blood; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016097:Simian Acquired Immunodeficiency Syndrome / Q000150:complications / Q000276:immunology / Q000503:physiopathology*; D015302:Simian Immunodeficiency Virus / Q000302:isolation & purification; D015996:Survival Rate; D016176:T-Lymphocyte Subsets / Q000276:immunology; D014759:Viral Envelope Proteins; D019562:Viral Load
chemical_list: D000914:Antibodies, Viral; D015699:HIV Envelope Protein gp120; D007074:Immunoglobulin G; D008562:Membrane Glycoproteins; D012367:RNA, Viral; D014759:Viral Envelope Proteins; C069623:gp120 protein, Simian immunodeficiency virus